Latest Tanabe Pharma News & Updates

See the latest news and media coverage for Tanabe Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Tanabe Pharma

Prescription drug developer

tanabe-pharma.com

Headquarters: Osaka, Japan
Founded year: 1678
Company type: Public company
Number of employees: 5,000–10,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Tanabe Pharma

In short: Tanabe Pharma underwent a major rebranding and leadership change following its $3.3 billion acquisition by Bain Capital from Mitsubishi.

Company announcements

July 3 Tanabe Pharma

Tanabe Pharma agrees to transfer subsidiary and product approvals

The subsidiary Tanabe Pharma Factory and marketing approvals for 17 products will be transferred to Towa Pharmaceutical, completing in stages from late 2026.

June 26 Tanabe Pharma

Tanabe Pharma announces regulatory approval of CANALIA Tablets in Thailand

The drug combines a DPP-4 inhibitor and SGLT2 inhibitor, targeting the estimated 6.4 million diabetes patients in Thailand.

June 1 Tanabe Pharma

Tanabe Pharma announces personnel changes

Koichi Itabashi appointed as executive officer, and the executive structure has been renewed.

May 18 Tanabe Pharma

Tanabe Pharma obtains additional indication approval for Zepbound

Approval for obstructive sleep apnea syndrome and obesity-related glucose intolerance, etc.

Media coverage

July 7 MarketWatch

Yomiuri: Towa Pharmaceutical Aims to Boost Production Capacity with Planned Acquisition of Tanabe Pharma Subsidiary

Towa Pharmaceutical Co., a major Japanese generic drugmaker, aims to "establish a system to increase production as soon as possible" amid concerns over a supply...

June 24 Witfire

Tanabe’s Uplizna Defense: Obexelimab Had Already Won Phase 3

SigHT is formally a long-term observational study. Strategically, its timing points to something larger: Tanabe is building a ...

June 3 The Globe and Mail

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

Detailed price information for Mineralys Therapeutics Inc (MLYS-Q) from The Globe and Mail including charting and trades.

April 2 MarketWatch

Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi

Tanabe Pharma America, Inc. (TPA), the wholly owned subsidiary of Tanabe Pharma Corporation, today announced the finalization of the transfer of the RADICAVA (edaravone) business...

Never miss news about Tanabe Pharma

Track Tanabe Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Tanabe Pharma competitors & trending companies

Browse news for competitors to Tanabe Pharma and other trending companies.